Covista Inc. vs UNIVERSAL TECHNICAL INSTITUTE, INC, two Education stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVSA and UTI diverge most: on fcf yield, CVSA reads 8.9% and UTI reads -2.0%; on operating margin, CVSA reads 19.0% and UTI reads 1.5%. The rest of the comparable metrics sit closer together. What CVSA's price implies is a bet that sits within the historical range (whole-company basis). What UTI's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVSA | UTI |
|---|---|---|
| Price | $129.69 | $20.64 |
| Market cap | $4.4B | $1.2B |
| Sector | Education | Education |
| Stage | Mature | Mature |
| Implied growth (priced in) | — | +12.8% |
| P/E | 18.4 | 33.8 |
| P/B | 3.05 | 3.35 |
| P/S | 2.26 | 1.31 |
| EV/EBITDA | 10.7 | 14.6 |
| Revenue growth | +9.3% | +9.2% |
| Operating margin | 19.0% | 1.5% |
| Net margin | 12.9% | 3.9% |
| Return on equity | 17.4% | 10.0% |
| Return on assets | 8.3% | 3.8% |
| Return on invested capital | 14.8% | 6.5% |
| FCF yield | 8.9% | -2.0% |
| Debt / equity | 0.46 | 0.46 |
| Current ratio | 1.09 | 1.30 |
| Altman Z (solvency) | 3.87 | 2.51 |
| Piotroski F (quality) | 5 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.